These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33829071)

  • 21. Effect of setup and inter-fraction anatomical changes on the accumulated dose in CT-guided breath-hold intensity modulated proton therapy of liver malignancies.
    Yang Z; Chang Y; Brock KK; Cazoulat G; Koay EJ; Koong AC; Herman JM; Park PC; Poenisch F; Li Q; Yang K; Wu G; Anderson B; Ohrt AN; Li Y; Zhu XR; Zhang X; Li H
    Radiother Oncol; 2019 May; 134():101-109. PubMed ID: 31005203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigating the utilization of beam-specific apertures for the intensity-modulated proton therapy (IMPT) head and neck cancer plans.
    Rana S; Storey M; Manthala Padannayil N; Shamurailatpam DS; Bennouna J; George J; Chang J
    Med Dosim; 2021 Summer; 46(2):e7-e11. PubMed ID: 33246881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anatomic changes in head and neck intensity-modulated proton therapy: Comparison between robust optimization and online adaptation.
    Lalonde A; Bobić M; Winey B; Verburg J; Sharp GC; Paganetti H
    Radiother Oncol; 2021 Jun; 159():39-47. PubMed ID: 33741469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparing cone-beam CT intensity correction methods for dose recalculation in adaptive intensity-modulated photon and proton therapy for head and neck cancer.
    Kurz C; Dedes G; Resch A; Reiner M; Ganswindt U; Nijhuis R; Thieke C; Belka C; Parodi K; Landry G
    Acta Oncol; 2015; 54(9):1651-7. PubMed ID: 26198654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose and robustness comparison of nominal, daily and accumulated doses for photon and proton treatment of sinonasal cancer.
    Argota-Perez R; Sharma MB; Elstrøm UV; Møller DS; Grau C; Jensen K; Holm AIS; Korreman SS
    Radiother Oncol; 2022 Aug; 173():102-108. PubMed ID: 35667574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PTV-based IMPT optimization incorporating planning risk volumes vs robust optimization.
    Liu W; Frank SJ; Li X; Li Y; Zhu RX; Mohan R
    Med Phys; 2013 Feb; 40(2):021709. PubMed ID: 23387732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical evaluation of synthetic computed tomography methods in adaptive proton therapy of lung cancer patients.
    Taasti VT; Hattu D; Peeters S; van der Salm A; van Loon J; de Ruysscher D; Nilsson R; Andersson S; Engwall E; Unipan M; Canters R
    Phys Imaging Radiat Oncol; 2023 Jul; 27():100459. PubMed ID: 37397874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intensity-modulated proton therapy (IMPT) interplay effect evaluation of asymmetric breathing with simultaneous uncertainty considerations in patients with non-small cell lung cancer.
    Shan J; Yang Y; Schild SE; Daniels TB; Wong WW; Fatyga M; Bues M; Sio TT; Liu W
    Med Phys; 2020 Nov; 47(11):5428-5440. PubMed ID: 32964474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Robust optimization of intensity modulated proton therapy.
    Liu W; Zhang X; Li Y; Mohan R
    Med Phys; 2012 Feb; 39(2):1079-91. PubMed ID: 22320818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The energy margin strategy for reducing dose variation due to setup uncertainty in intensity modulated proton therapy (IMPT) delivered with distal edge tracking (DET).
    Zhang M; Flynn RT; Mo X; Mackie TR
    J Appl Clin Med Phys; 2012 Sep; 13(5):3863. PubMed ID: 22955652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple Computed Tomography Robust Optimization to Account for Random Anatomic Density Variations During Intensity Modulated Proton Therapy.
    Zhu M; Kaiser A; Mishra MV; Kwok Y; Remick J; DeCesaris C; Langen KM
    Adv Radiat Oncol; 2020; 5(5):1022-1031. PubMed ID: 33083665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A robust intensity modulated proton therapy optimizer based on Monte Carlo dose calculation.
    Ma J; Wan Chan Tseung HS; Herman MG; Beltran C
    Med Phys; 2018 Jul; ():. PubMed ID: 30019423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Robust treatment planning with conditional value at risk chance constraints in intensity-modulated proton therapy.
    An Y; Liang J; Schild SE; Bues M; Liu W
    Med Phys; 2017 Jan; 44(1):28-36. PubMed ID: 28044325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ART for head and neck patients: On the difference between VMAT and IMPT.
    Góra J; Kuess P; Stock M; Andrzejewski P; Knäusl B; Paskeviciute B; Altorjai G; Georg D
    Acta Oncol; 2015; 54(8):1166-74. PubMed ID: 25850583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Head and neck IMPT probabilistic dose accumulation: Feasibility of a 2 mm setup uncertainty setting.
    Wagenaar D; Kierkels RGJ; van der Schaaf A; Meijers A; Scandurra D; Sijtsema NM; Korevaar EW; Steenbakkers RJHM; Knopf AC; Langendijk JA; Both S
    Radiother Oncol; 2021 Jan; 154():45-52. PubMed ID: 32898561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multi-scenario based robust intensity-modulated proton therapy (IMPT) plans can account for set-up errors more effectively in terms of normal tissue sparing than planning target volume (PTV) based intensity-modulated photon plans in the head and neck region.
    Stuschke M; Kaiser A; Abu Jawad J; Pöttgen C; Levegrün S; Farr J
    Radiat Oncol; 2013 Jun; 8():145. PubMed ID: 23773560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigating deformable image registration and scatter correction for CBCT-based dose calculation in adaptive IMPT.
    Kurz C; Kamp F; Park YK; Zöllner C; Rit S; Hansen D; Podesta M; Sharp GC; Li M; Reiner M; Hofmaier J; Neppl S; Thieke C; Nijhuis R; Ganswindt U; Belka C; Winey BA; Parodi K; Landry G
    Med Phys; 2016 Oct; 43(10):5635. PubMed ID: 27782706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Knowledge-Based Planning for Robustly Optimized Intensity-Modulated Proton Therapy of Head and Neck Cancer Patients.
    Xu Y; Cyriac J; De Ornelas M; Bossart E; Padgett K; Butkus M; Diwanji T; Samuels S; Samuels MA; Dogan N
    Front Oncol; 2021; 11():737901. PubMed ID: 34737954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment planning comparison of IMPT, VMAT and 4π radiotherapy for prostate cases.
    Tran A; Zhang J; Woods K; Yu V; Nguyen D; Gustafson G; Rosen L; Sheng K
    Radiat Oncol; 2017 Jan; 12(1):10. PubMed ID: 28077128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intensity-modulated proton therapy (IMPT) versus intensity-modulated radiation therapy (IMRT) for the treatment of head and neck cancer: A dosimetric comparison.
    Nguyen ML; Cantrell JN; Ahmad S; Henson C
    Med Dosim; 2021 Autumn; 46(3):259-263. PubMed ID: 33648823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.